Kosuke Kaji

3.7k total citations
126 papers, 2.5k citations indexed

About

Kosuke Kaji is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Kosuke Kaji has authored 126 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 69 papers in Hepatology and 31 papers in Surgery. Recurrent topics in Kosuke Kaji's work include Liver Disease Diagnosis and Treatment (71 papers), Liver Disease and Transplantation (38 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). Kosuke Kaji is often cited by papers focused on Liver Disease Diagnosis and Treatment (71 papers), Liver Disease and Transplantation (38 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). Kosuke Kaji collaborates with scholars based in Japan, United States and Denmark. Kosuke Kaji's co-authors include Hitoshi Yoshiji, Tadashi Namisaki, Hideto Kawaratani, Mitsuteru Kitade, Takemi Akahane, Ryuichi Noguchi, Hiroshi Fukui, Kei Moriya, Hiroaki Takaya and Yasuhide Ikenaka and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Kosuke Kaji

119 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kosuke Kaji Japan	27	1.1k	902	786	452	428	126	2.5k
Tomonori Aoyama Japan	20	1.6k 1.5×	1.1k 1.2×	773 1.0×	412 0.9×	286 0.7×	34	2.9k
Tadashi Namisaki Japan	29	1.5k 1.4×	1.2k 1.3×	952 1.2×	500 1.1×	539 1.3×	159	3.3k
S. Saccomanno Italy	22	1.3k 1.1×	838 0.9×	697 0.9×	615 1.4×	539 1.3×	42	2.4k
Mitsuteru Kitade Japan	32	1.2k 1.0×	1.2k 1.3×	1.2k 1.5×	572 1.3×	464 1.1×	88	3.2k
Eitaro Taniguchi Japan	27	1.1k 1.0×	1.2k 1.3×	832 1.1×	420 0.9×	285 0.7×	66	2.9k
Takemi Akahane Japan	24	766 0.7×	529 0.6×	565 0.7×	280 0.6×	234 0.5×	108	1.8k
Akinobu Takaki Japan	33	1.8k 1.6×	1.8k 2.0×	931 1.2×	603 1.3×	314 0.7×	152	3.6k
Fouad Lafdil France	25	1.2k 1.1×	912 1.0×	646 0.8×	356 0.8×	216 0.5×	36	2.8k
Alessandra Gentilini Italy	20	1.1k 1.0×	1.3k 1.4×	578 0.7×	570 1.3×	182 0.4×	34	2.3k
Yasuhide Ikenaka Japan	27	1.1k 1.0×	1.3k 1.4×	896 1.1×	330 0.7×	452 1.1×	55	2.9k

Countries citing papers authored by Kosuke Kaji

Since Specialization

Citations

This map shows the geographic impact of Kosuke Kaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Kaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Kaji more than expected).

Fields of papers citing papers by Kosuke Kaji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Kaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Kaji. The network helps show where Kosuke Kaji may publish in the future.

Co-authorship network of co-authors of Kosuke Kaji

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Kaji. A scholar is included among the top collaborators of Kosuke Kaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Kaji. Kosuke Kaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oyama, Masafumi, Tadashi Namisaki, Satoshi Iwai, et al.. (2025). Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD. International Journal of Molecular Sciences. 26(19). 9560–9560.

Kubo, Takahiro, Norihisa Nishimura, Kosuke Kaji, et al.. (2024). Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment. International Journal of Molecular Sciences. 25(8). 4405–4405. 3 indexed citations

Asada, Shohei, Kosuke Kaji, Norihisa Nishimura, et al.. (2024). Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats. Cells. 13(6). 538–538. 14 indexed citations

Iwai, Satoshi, Takemi Akahane, Hiroaki Takaya, et al.. (2024). Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis. Hepatology Research. 54(12). 1116–1127. 1 indexed citations

Moriya, Kei, Shinya Sato, Norihisa Nishimura, et al.. (2023). Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis. Journal of Clinical Medicine. 12(13). 4463–4463. 2 indexed citations

Takaya, Hiroaki, Tadashi Namisaki, Takahiro Kubo, et al.. (2023). The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology. 12(2). 164–164. 4 indexed citations

Yoshizaki, Yuta, Takuya Nagata, Kengo Suzuki, et al.. (2023). Drug Delivery with Hyaluronic Acid-Coated Polymeric Micelles in Liver Fibrosis Therapy. ACS Biomaterials Science & Engineering. 9(6). 3414–3424. 14 indexed citations

Suzuki, Junya, Kosuke Kaji, Norihisa Nishimura, et al.. (2023). A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines. 11(5). 1295–1295. 5 indexed citations

Kaji, Kosuke, Norihisa Nishimura, Takahiro Kubo, et al.. (2023). Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity. Cells. 12(5). 687–687. 16 indexed citations

10.

Fujinaga, Yukihisa, Tadashi Namisaki, Yuki Tsuji, et al.. (2022). Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis. International Journal of Molecular Sciences. 23(17). 9814–9814. 2 indexed citations

11.

Takaya, Hiroaki, Tadashi Namisaki, Shohei Asada, et al.. (2022). ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. Journal of Clinical Medicine. 11(7). 1835–1835. 7 indexed citations

12.

Takeda, Soichi, Tadashi Namisaki, Yuki Fujimoto, et al.. (2022). Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study. Anticancer Research. 42(11). 5465–5473. 6 indexed citations

13.

Kitagawa, Koh, Akira Mitoro, Takahiro Ozutsumi, et al.. (2021). Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study. Clinical Endoscopy. 55(3). 434–442. 4 indexed citations

14.

Akahane, Takemi, Daisuke Kaya, Ryuichi Noguchi, et al.. (2021). Association between Equol Production Status and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 22(21). 11904–11904. 8 indexed citations

15.

Takaya, Hiroaki, Tadashi Namisaki, Soichi Takeda, et al.. (2021). The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria. Journal of Clinical Medicine. 10(21). 4838–4838. 6 indexed citations

16.

Kaji, Kosuke, Norihisa Nishimura, Koji Ishida, et al.. (2021). The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. Cells. 10(3). 575–575. 23 indexed citations

17.

Nishimura, Norihisa, Kosuke Kaji, Koh Kitagawa, et al.. (2021). Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. International Journal of Molecular Sciences. 22(13). 6921–6921. 30 indexed citations

18.

Fujinaga, Yukihisa, Hideto Kawaratani, Daisuke Kaya, et al.. (2020). Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 21(15). 5589–5589. 29 indexed citations

19.

Kaneko, Miki, Tadashi Namisaki, Hiroaki Takaya, et al.. (2019). Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report. Journal of Medical Case Reports. 13(1). 64–64. 2 indexed citations

20.

Kitade, Mitsuteru, Hitoshi Yoshiji, Ryuichi Noguchi, et al.. (2009). Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis. World Journal of Gastroenterology. 15(41). 5193–5193. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact